Equipped with a color 3-D camera, an inertial measurement sensor and its own onboard computer, a newly improved robotic cane could offer blind and visually impaired users a new way to navigate indoors.

A new study lays the groundwork for potential new therapies for progressive multiple sclerosis. Chronic lesions with inflamed rims, or “smoldering” plaques, in the brains of people with MS have been linked to more aggressive and disabling forms of the disease.

Computer tests of attention and focus revealed that older adults declined in 1 one out of 3 key brain functions. The other functions actually improved during aging, at least until the mid-to-late 70s.

An investigational HIV vaccine tested in sub-Saharan Africa posed no safety concerns but did not sufficiently protect against HIV infection.

Researchers from NCI and Washington University School of Medicine have developed a blood test that, they believe, could one day offer a highly sensitive and inexpensive approach to detect cancer early in people with NF1.

An NIA-supported study estimated that Covid-19 vaccinations prevented nearly 140,000 deaths in the U.S. by May 2021.

One dose of a new monoclonal antibody discovered and developed at NIH safely prevented malaria for up to 9 months in people exposed to the malaria parasite. The small clinical trial is the first to demonstrate that a monoclonal antibody can prevent malaria in people.

A new study suggests a single 2-hour session of a pain management skills class could offer as much benefit as 8 sessions of cognitive behavioral therapy for patients experiencing chronic low-back pain. Supported by NCCIH and NIDA, the study explored whether a compressed intervention could lead to the same benefits as a longer course of CBT.

A nasal spray of the Oxford/AstraZeneca Covid-19 vaccine protected hamsters and monkeys against serious disease and reduced the amount of virus in the nose. Less virus in the nasal passages could reduce the risk that vaccinated individuals spread the virus.

NEI-funded research offers a new path for preventing glaucoma vision loss. A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma.